Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 4.0B | 4.1B | 4.1B | 4.5B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 407M | 389M | 388M | 388M |
| Other operating expenses | 150M | 146M | 149M | 407M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 2.2B | 2.2B | 2.2B | 2.3B |
| Tax provision | 715M | 624M | 639M | 648M |
| Net income | 1.5B | 1.5B | 1.6B | 1.7B |
| Basic EPS | — | 0.2 | 0.2 | 0.2 |
| Diluted EPS | — | 0.2 | 0.2 | 0.2 |
| Basic average shares | — | 7.1B | 7.2B | 7.3B |
| Diluted average shares | — | 7.1B | 7.2B | 7.3B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | -1M | -2M | -3M | -1M |
| Preferred stock dividends | — | — | — | — |